Anti-CD38 antibody Injection

DRUG3 trials

Sponsors

Institute of Hematology & Blood Diseases Hospital, China

Conditions

Antiphospholipid SyndromeEvan SyndromeImmune ThrombocytopeniaThrombocytopeniaTreatment

Phase 2

Anti-CD38 Antibody Treating APS With Thrombocytopenia

RecruitingNCT05983952

Institute of Hematology & Blood Diseases Hospital, ChinaAntiphospholipid Syndrome, Thrombocytopenia

Start: 2023-08-01End: 2025-08-31Target: 10Updated: 2025-08-05

Anti-CD38 Antibody Treating Evans Syndrome

RecruitingNCT06014775

Institute of Hematology & Blood Diseases Hospital, ChinaEvan Syndrome, Treatment

Start: 2023-12-01End: 2025-08-31Target: 10Updated: 2025-02-21

Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)

RecruitingNCT06168851

Institute of Hematology & Blood Diseases Hospital, ChinaImmune Thrombocytopenia, Treatment

Start: 2023-12-28End: 2030-12-31Target: 60Updated: 2025-11-28